Related by context. All words. (Click for frequent words.) 73 proband 69 nonpsychotic 66 familial aggregation 66 euthymic patients 64 familial pancreatic cancer 64 dizygotic twins 64 multivariate analyzes 63 fraternal twin pairs 63 affective disorders 63 nondepressed 63 autistic traits 62 5 HTTLPR 62 multivariable analysis 62 BRCA2 mutation carriers 62 allele frequencies 62 affective disorder 62 #q#.# deletion syndrome 62 affective psychosis 62 advanced neoplasia 61 schizophreniform disorder 61 penetrance 61 alexithymia 61 HNPCC 61 #q# [001] 61 dysthymia 61 nondemented 61 CDKN2A 61 monozygotic 61 sporadic ALS 61 #q# deletion syndrome 61 IgA deficiency 61 DRD2 61 univariate analysis 61 C#Y 60 internalizing disorders 60 dizygotic 60 comorbid anxiety 60 cognitively normal 60 unipolar depression 60 CDH1 60 TT genotype 60 bivariate analyzes 60 CC genotype 60 chronicity 60 logistic regression analysis 60 multivariable analyzes 60 rs# [004] 60 missense mutations 60 sociodemographic variables 60 DSM IV diagnosis 60 psychiatric morbidity 60 APOE e4 60 rs# [001] 60 suicide attempters 60 colorectal neoplasia 60 univariate analyzes 60 IL#B 60 seropositivity 60 familial ALS 60 depressive symptomatology 60 logistic regression model 60 dyads 60 % CI #.#-#.# [007] 59 premorbid 59 thrombophilia 59 neurocognitive impairment 59 homozygotes 59 neurological abnormalities 59 APOE ε4 59 sCJD 59 affective psychoses 59 heterozygotes 59 retrospective cohort 59 APOE genotype 59 monozygotic twins 59 psychosocial functioning 59 MLH1 59 amnestic MCI 59 psychiatric outpatients 59 psychiatric diagnoses 59 #q# deletion 59 PTPN# 59 IPAH 59 haplotypes 58 GBA mutations 58 de novo AML 58 KRAS mutations 58 rs# [003] 58 psychiatric comorbidities 58 NNRTI resistance 58 MMSE scores 58 monozygotic twin 58 inherited mutations 58 elevated ALT 58 BRCA mutation 58 genotyped 58 HIV uninfected 58 comorbidity 58 differentially expressed genes 58 % CI #.#-#.# [003] 58 UGT#A# * 58 parous women 58 BRCA2 carriers 58 autosomal dominant inheritance 58 prepubertal 58 TACI mutations 58 univariate 58 heterozygous 58 familial clustering 58 nondiabetic 58 pCR 58 germline mutations 58 genomewide 58 genetic variants associated 58 Univariate analysis 58 covariate 58 orthologs 58 diffuse gastric 58 hyper IgE syndrome 58 DQB1 * 58 kidney allograft 58 Multivariate analysis 58 MMSE score 58 bivariate 57 Suicidal ideation 57 mg BID dose 57 definite stent thrombosis 57 subsyndromal 57 prospectively defined 57 T2DM 57 genotypic 57 BRCA2 mutation 57 mutant allele 57 microdeletion 57 T1DM 57 #p#.# [002] 57 EoE 57 neuropsychological impairments 57 atopic 57 SRBD 57 GH deficiency 57 comorbid psychiatric 57 BRCA gene mutations 57 Heritability 57 hyperkinetic disorder 57 BRCA2 mutations 57 comorbid disorders 57 homozygosity 57 prostate cancer CaP 57 microsatellite instability 57 SNP rs# [002] 57 haematological 57 renal cell carcinomas 57 Bonferroni correction 57 thyrotropin levels 57 subscale scores 57 BRAF mutations 57 schizophrenia schizoaffective disorder 57 heterozygosity 57 contralateral breast cancer 57 dopamine transporter gene 57 histological subtype 57 del 5q 57 habitual snoring 57 serum estradiol 57 autonomic dysfunction 57 hepatocellular carcinomas 57 plasma folate 57 postintervention 57 Recurrence Score 56 syndromal 56 EpCAM expression 56 depressive symptoms 56 nodal metastases 56 CR nPR 56 endophenotypes 56 ε4 56 aged ≥ 56 shorter telomere length 56 schizotypal traits 56 deletion 5q 56 DRD4 56 somatic symptoms 56 Clusterin 56 seronegative 56 MGUS 56 BRCA1 mutations 56 serum IGF 56 sociodemographic characteristics 56 sociodemographic factors 56 HER2 expression 56 genotypic resistance 56 dopamine receptor gene 56 generalized estimating 56 subclinical atherosclerosis 56 hematopoietic cancers 56 Multivariate analyzes 56 mRNA expression 56 euthymic 56 chromosome #p# [002] 56 T1D 56 linkage disequilibrium 56 neurodevelopmental impairment 56 bivariate analysis 56 dysbindin 56 white matter hyperintensities 56 genetic loci 56 BRAF V#E 56 aortic atherosclerosis 56 multiple logistic regression 56 Depressive symptoms 56 K ras mutations 56 subclinical hypothyroidism 56 hippocampal volume 56 AUDs 56 unmeasured confounders 56 HBeAg 56 comorbid 56 ragweed allergic 56 dysglycemia 56 clinicopathological 56 schizotypal 56 ependymomas 56 nonpregnant women 56 HSCT 56 subclinical hyperthyroidism 56 virological response 56 baseline LDH 56 VaD 56 HRQoL 56 advanced adenoma 56 HLA B 55 bulimia nervosa 55 LQTS 55 confidence interval #.#-#.# 55 HRQL 55 karyotypes 55 TRAF1 C5 55 preintervention 55 comorbid depression 55 LRRK2 mutation 55 psychiatric comorbidity 55 genotype phenotype 55 fractional anisotropy 55 BRCA1 mutation carriers 55 spontaneous mutations 55 genetic polymorphisms 55 FLT3 55 familial AF 55 clinicopathological features 55 cryptorchidism 55 lymphocyte count 55 astrocytomas 55 underwent CABG 55 autosomal 55 CIN2 + 55 atopy 55 posttransplant 55 chromosome #q#.# [001] 55 sd = 55 phenotypes 55 BRCA mutations 55 parkinsonism 55 PCa 55 citalopram 55 Cognitive impairment 55 variant alleles 55 airway responsiveness 55 BMI z 55 prognostic factors 55 homozygous 55 conditional logistic regression 55 recurrent VTE 55 lymphocytosis 55 nonobese 55 neuropathologic 55 somatization disorder 55 APOE4 55 operable breast cancer 55 venlafaxine XR 55 LTBI 55 HER2 overexpression 55 T2D 55 Logistic regression 55 rheumatoid factor 55 telomere lengths 55 TEAEs 55 IKZF1 55 % Confidence Interval 55 catechol O methyltransferase 55 response pCR 55 allelic 55 idiopathic PAH 55 rCBF 55 MSH2 55 Li Fraumeni syndrome 55 PTEN mutations 55 MetS 55 extramedullary 55 serous ovarian cancer 55 nonexposed 55 HRCT 55 allele 55 thyroid carcinoma 55 normal karyotype 55 liver histology 55 phylogenetic analyzes 55 narcolepsy cataplexy 55 baseline HbA1c 55 autosomal dominant disorder 55 #q#.# [002] 55 rs# [002] 55 ADRB2 55 polymorphism 55 seroconverted 55 alleles 55 comorbid diagnoses 55 carotid IMT 55 APOE gene 55 CNTNAP2 55 atypical hyperplasia 55 loci 55 HGPIN 55 HIV HCV coinfected 55 androgen suppression 55 liver transplant recipients 55 logistic regression analyzes 55 obstructive coronary artery 55 odds ratios ORs 55 SNP rs# [001] 55 GSTM1 55 ApoE4 gene 55 NF1 55 distant metastasis 55 logistic regression models 55 timepoints 55 prevalences 55 serum urate levels 55 HBeAg negative 55 THIS STUDY 55 advanced adenomas 55 isolated systolic hypertension 54 TOP2A 54 serum concentrations 54 lymph node metastasis 54 extrapyramidal symptoms 54 chromosomal regions 54 MADRS score 54 NRTI resistance 54 sociodemographic 54 HLA B# 54 p = .# [002] 54 multivariable adjusted 54 ELBW infants 54 FEV ^ sub 54 autoimmune thyroid 54 EGFR mutations 54 Baseline characteristics 54 neutrophil counts 54 ADPKD 54 pancreatic adenocarcinoma 54 homozygote 54 allelic variants 54 prospective longitudinal 54 LV dysfunction 54 gene expression profiles 54 pathogenic mutations 54 Subgroup analysis 54 serum vitamin D 54 neuroimaging studies 54 apolipoprotein E 54 Kaplan Meier analysis 54 behavioral disinhibition 54 potential confounders 54 antibody titer 54 Genotypes 54 invasive carcinomas 54 ALT flares 54 corticosterone levels 54 HBsAg 54 ABCB1 54 nonhereditary 54 subthreshold 54 microdeletions 54 TYMS 54 cognitively intact 54 intraobserver 54 suicidal ideation 54 CYP#D# genotype 54 SLITRK1 54 hydroxyvitamin D levels 54 non affective psychosis 54 VADT 54 genotypes 54 cerebral microbleeds 54 neuroleptic 54 CNVs 54 gene polymorphisms 54 variant allele 54 highest tertile 54 BMPR2 54 hippocampal volumes 54 testicular germ cell 54 multivariate Cox 54 coronary calcification 54 subclinical 54 GABRA2 54 VUR 54 genes predisposing 54 bronchopulmonary dysplasia 54 externalizing disorders 54 recessive inheritance 54 CYP#D# 54 preoperative PSA 54 clinico pathological 54 GSTP1 54 serum samples 54 pilocytic astrocytomas 54 generalized epilepsy 54 gastric carcinoma 54 neuroblastomas 54 confidence intervals CIs 54 covariates 54 diabetes mellitus DM 54 thyroglobulin 54 CANCIDAS 54 FASPS 54 evaluable subjects 54 cognitive domains 54 susceptibility loci 54 susceptibility genes 54 SLC#A# [002] 54 promoter polymorphism 54 adiponectin concentrations 54 Subgroup analyzes 54 hypogonadotropic hypogonadism 54 highly heritable 54 polygenic 54 pg ml 54 cranial irradiation 54 tryptophan depletion 54 chromosome #q# [001] 54 dysthymic disorder 54 chromosome #q 54 Stuttering tends 54 imipramine 54 CALGB 54 psychopathology 54 #q#.# [001] 54 allele frequency 54 MLL2 54 airway hyperresponsiveness 53 monoclonal gammopathy 53 Structured Clinical 53 SLNB 53 biochemical recurrence 53 APOE allele 53 #q# [002] 53 mosaicism 53 HT 2A 53 CYP#C# [001] 53 inbred strains 53 carotid stenosis 53 callous unemotional traits 53 chromosomal anomaly 53 glutamic acid decarboxylase 53 multivariate adjustment 53 lymphoproliferative disorders 53 mutated K ras 53 cognitive affective 53 underwent resection 53 GG genotype 53 hypoperfusion 53 myeloproliferative neoplasms 53 elevated LDH 53 HLA DRB1 53 mammographic density 53 perimenopausal women 53 nondiabetic patients 53 ERBB2 53 TP# mutations 53 haplotype 53 multivariate logistic regression 53 hamartomas 53 HDRS 53 troponin T 53 symptom severity 53 histologic subtype 53 Poisson regression 53 genetic polymorphism 53 PsA 53 immunostaining 53 sensory gating 53 heritability 53 psychiatric disorders 53 euthyroid 53 somatic mutations 53 HLA identical 53 atherothrombotic disease 53 etiologic 53 Suicidal thoughts 53 #p# [003] 53 ARVD 53 BRCA mutation carriers 53 colorectal carcinomas 53 DRD2 gene 53 HCV infected 53 SGPT 53 clusterin 53 invasive ductal 53 nonfatal MI 53 internalizing behaviors 53 relapsed MM 53 abnormal cytology 53 CIN3 53 SIDS infants 53 histologically confirmed 53 immunoreactivity 53 % CI #.#-#.# [008] 53 chromosomal alterations 53 recurrent UTI 53 confidence interval CI 53 anemia hemoglobin 53 ORMDL3 53 HER2 homodimer levels 53 neurodevelopmental outcomes 53 neuropsychiatric disorder 53 KIBRA 53 maternal serum 53 explanatory variables 53 df = 53 serum cortisol 53 ApoE4 53 ependymoma 53 imatinib therapy 53 missense mutation 53 aminotransferase levels 53 DAT1 53 multivariate analysis 53 COMT genotype 53 nonadherence 53 psychotic disorders 53 alanine aminotransferase ALT 53 serum folate 53 H#K#me# 53 assortative mating 53 APOC3 53 dopamine D4 receptor 53 intensive statin therapy 53 attention-deficit/hyperactivity disorder ADHD 53 Sociodemographic 53 HeFH 53 autosomal dominant 53 neurodevelopmental disability 53 SNPs 53 NOMID 53 HYVET 53 leukemia AML 53 CCyR 53 nonpsychiatric 53 psychotic symptoms 53 salivary cortisol 53 serum selenium 53 biochemical relapse 53 breast cancer susceptibility genes 53 colorectal adenomas 53 comorbidities 53 lymph node involvement 53 HLA DR 53 genetic relatedness 53 virological failure 53 asthma exacerbation 53 HLA DR4 53 interobserver 53 MYCN amplification 53 plasma creatinine 53 differentially regulated 53 serum lipid levels 53 MRSA isolates 53 Montgomery Åsberg Depression 53 polymorphisms 53 nulliparous women 53 CCR5 delta# 53 EBV infection 53 R#W [002] 53 differential gene expression 53 neuropsychiatric symptoms 53 metabolite concentrations 53 DSM IV criteria 53 ECOG PS 53 HRQOL 53 FDG PET scans 53 VCFS 53 β amyloid 53 depressive symptom 53 ELBW 53 smoldering myeloma 53 microscopic hematuria 53 CVD mortality 53 POAG 53 5q 53 poor metabolizers 53 elevated triglyceride levels 53 underwent radical prostatectomy 53 somatoform disorders 52 cTnI 52 5 HTTLPR genotype 52 repeat allele 52 mg/m2 dose 52 HIV seronegative 52 indels 52 chromosome #p#.# 52 mesotheliomas 52 brain lesions 52 randomized controlled trials RCTs 52 Platelet counts 52 mtDNA mutations 52 umol L 52 febrile seizure 52 fasting insulin 52 biopsy Gleason 52 virologic failure 52 mood dysregulation 52 SDQ 52 BCG vaccinated 52 neurocognitive functioning 52 serum creatinine levels 52 orthologous genes 52 BRCA testing 52 GH deficient 52 socioeconomic status SES 52 azoospermia 52 lymphopenia 52 cystatin C 52 interindividual variability 52 histologically proven 52 ApoE gene 52 de novo mutations 52 neuropsychological deficits 52 galiximab 52 MECP2 gene 52 LRRK2 mutations 52 clinicopathologic 52 hemodynamically significant 52 undergone radical prostatectomy 52 Univariate 52 immunoreactive 52 Cytogenetic 52 Leydig cell 52 psychopathological symptoms 52 NHANES III 52 normal birthweight 52 apoE4 52 adjunctive placebo 52 HLA DRB1 * 52 familial hypercholesterolemia 52 grade cervical intraepithelial 52 temporal cortex 52 serologic 52 mCRC patients 52 DSM IV Axis 52 coinfected 52 APOE4 gene 52 osteosarcomas 52 methotrexate monotherapy 52 autosomal recessive 52 Mood disorders 52 pDCs 52 plasma cortisol 52 androgen depletion 52 chromosome #p# [001] 52 prior chemotherapy regimens 52 G#S mutation 52 salmeterol HFA MDI 52 Posttraumatic stress disorder 52 PSADT 52 KIF6 gene 52 Sjögren syndrome 52 ALT elevations 52 neurocognitive function 52 antibody titers 52 multivariable Cox 52 Swedish Mammography Cohort 52 nonmetastatic 52 symptomatology 52 breast cancer subtypes 52 CHEK2 52 posttreatment 52 postnatally 52 born preterm 52 lupus anticoagulant 52 acute lymphoid leukemia 52 TMC# r 52 NIHSS score 52 autopsied brains 52 extraversion 52 HBeAg positive 52 compulsive hoarding syndrome 52 underwent surgical resection 52 predictive validity 52 prostate adenocarcinoma 52 medulloblastomas 52 receiving VICTRELIS 52 Non inferiority 52 Neuroticism 52 nmol L. 52 serum testosterone 52 TTR gene 52 TCF#L# gene 52 % CI #.#-#.# [006] 52 posterior cingulate 52 paternally inherited 52 essential thrombocythemia 52 T2 lesions 52 activating mutations 52 paragangliomas 52 EDSS score 52 Multiple logistic regression 52 elevated depressive symptoms 52 gene APOE 52 C#BL/#J 52 recurrent ischemic stroke 52 tHcy 52 SUVmax 52 antidepressant efficacy 52 chromosomal defect 52 abnormal lipid 52 chlamydial infection 52 PBMCs 52 RLS sufferers 52 albumin excretion 52 G allele 52 Wisconsin Sleep Cohort 52 Longitudinal studies 52 K#R [002] 52 activating mutation 52 neurocognitive deficits 52 VKORC1 52 RRM1 52 n = 52 nucleotide substitutions 52 EDSS scores 52 atrophic gastritis 52 autoantibody positive 52 comorbid conditions 52 autistic regression 52 chromosomal anomalies 52 Wwox 52 asymptomatic PAD 52 gestational diabetes mellitus 52 FLT3 ITD 52 K ras mutation 52 ASD prevalence 52 Flu Cy 52 phenotype 52 pediatric bipolar disorder 52 TGFBR1 * 6A 52 karyotype 52 hematologic toxicity 52 hippocampal atrophy 52 Exclusion criteria 52 genotype 52 multiple linear regression 52 PON1 52 interobserver reliability 52 FDG uptake 52 interrater reliability 52 thiopurine 52 severe neutropenia 52 syngeneic 52 mg kg dose 52 carcinoid 52 hepatic enzyme 52 prenatally diagnosed 52 patients evaluable 52 diastolic hypertension 52 T#I [002] 52 consanguineous 52 subtrochanteric 52 psychotic illnesses 52 carcinoembryonic antigen 52 aMCI 52 singleton pregnancies 52 myeloproliferative diseases 52 JAK mutations 52 neoplasm 52 peripheral blood mononuclear 52 APOE e4 gene 52 epithelial tumors 52 nonautistic 52 miRNA expression 52 MELD scores 52 isoprostane 52 Nicotine dependence 52 MAOA 52 sibling grandparent 52 alanine aminotransferase 52 #p#.# [001] 52 serologically 52 ERCC1 52 lymphovascular invasion 52 CORE OM 52 Index CDAI 52 neurofibrillary 52 venous thrombosis 52 VNTR 52 μmol L 52 prognostic variables 52 Arch Intern Med 52 atrioventricular block 52 testicular tumors 52 hypochondriasis 52 CaP 51 lowest tertile 51 DRB1 * 51 Framingham Offspring Study 51 ECOG 51 prolactin levels 51 pheochromocytoma 51 PNH patients 51 Major depressive disorder 51 hypersomnia 51 gadolinium enhanced 51 thrombocytopenic 51 intraclass correlation coefficients 51 prognostic indicators 51 confounders 51 EGFR mutation status 51 HOMA IR 51 functional polymorphism 51 recessive mutations 51 Neuregulin 1 51 SGAs 51 SSc 51 PALB2 51 tPSA 51 breast carcinoma 51 nulliparous 51 statistical significance p 51 transaminase elevations 51 revascularizations 51 Brugada syndrome 51 COMT gene 51 differentially expressed 51 ALT elevation 51 KCNH2 51 Haptoglobin 51 apolipoprotein E gene 51 KRAS oncogene 51 bronchopulmonary dysplasia BPD 51 coinfection 51 lumbar disc disease 51 unfavorable cytogenetics 51 hypopituitarism 51 chromosomal aberrations 51 subtype 51 retrospectively analyzed 51 haematologic 51 glucocorticoid receptors 51 visceral metastases 51 convergent validity 51 QoL 51 URTI 51 variance ANOVA 51 vertebral fracture 51 amisulpride 51 mutant alleles 51 prodromal 51 Framingham Offspring 51 coinfected patients 51 atopic disorders 51 daunorubicin 51 non syndromic 51 ASDs 51 pretransplant 51 systolic dysfunction 51 #p# [001] 51 relapsed AML 51 CYP#C# [002] 51 renal tumors 51 fasting triglyceride levels 51 chromosomal rearrangement 51 chest radiographs 51 cystatin 51 TIMP 1 51 chi ^ sup 51 menarche 51 asymptomatic carotid stenosis 51 infarcts 51 phenotypic variation 51 p# activation 51 #.#ng/ml 51 hierarchical clustering 51 supratentorial 51 heavily pretreated 51 noncarriers 51 HIV coinfected 51 inherited genetic mutations 51 primary aldosteronism 51 atypical hemolytic uremic syndrome 51 PSA nadir 51 parous 51 attain statistical significance 51 opioid dependent 51 SNHL 51 Brief Psychiatric 51 HLA alleles 51 CagA 51 recurrent miscarriage 51 eplerenone 51 ZNF# 51 circadian genes 51 febrile seizures 51 serum BDNF 51 Mental retardation 51 pT3 51 neurosensory 51 sleeve lobectomy 51 epithelial ovarian cancer 51 chi squared 51 microalbuminuria 51 variant rs# 51 DLTs 51 ANOVA 51 elevated serum ALT 51 antiretroviral naïve 51 Haplogroup 51 bipolar affective disorder 51 EEGs 51 seminomas 51 GSTM1 gene 51 Leukemias 51 cytopenias 51 Stent thrombosis 51 arterial thickening 51 extensive metabolizers 51 activity MAOA 51 neurocognitive disorder 51 chorioamnionitis 51 normotensive 51 unfavorable prognostic 51 amygdala reactivity 51 CR CRu 51 neuroticism 51 REYATAZ r arm 51 nonfasting triglyceride levels 51 locoregional recurrence 51 liver metastasis 51 de ath 51 COMT 51 antenatal depression 51 cytogenetic abnormalities 51 JAK2 V#F 51 nmol L 51 serum calcium levels 51 adenotonsillectomy 51 HbA 1c levels 51 nanomolar 51 adenomatous polyps 51 clinically asymptomatic 51 exomes 51 nonischemic 51 splice variants 51 DRD4 gene 51 hyperprolactinemia 51 depression suicidality 51 dietary folate intake 51 cortical activation 51 FLT3 mutations 51 CI = 51 leukemia ALL 51 nonmelanoma skin cancers 51 EEG recordings 51 microsatellite markers 51 inhibin B 51 Severe Primary IGFD 51 plasma pharmacokinetics 51 haplogroups 51 unmeasured confounding 51 antiphospholipid antibodies 51 hereditary hemochromatosis 51 SNCA 51 BRCA carriers 51 lung metastases 51 RRMS patients 51 hereditary nonpolyposis colorectal cancer 51 BRAF mutation 51 Comorbid 51 allergic sensitization 51 Acute Myeloid Leukaemia AML 51 serum HBV DNA 51 syndromic 51 chromosome #q# [002] 51 ataxias 51 hip BMD 51 tipranavir r 51 basal cell carcinoma BCC 51 subgroup analyzes 51 interquartile range